distinct crispr arrays Search Results


95
ATCC distinct crispr arrays
Distinct Crispr Arrays, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/distinct crispr arrays/product/ATCC
Average 95 stars, based on 1 article reviews
distinct crispr arrays - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

96
Addgene inc pspcas9 bb 2a gfp
Pspcas9 Bb 2a Gfp, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pspcas9 bb 2a gfp/product/Addgene inc
Average 96 stars, based on 1 article reviews
pspcas9 bb 2a gfp - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

90
Broad Institute Inc crispr/cas9 system
Crispr/Cas9 System, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/crispr/cas9 system/product/Broad Institute Inc
Average 90 stars, based on 1 article reviews
crispr/cas9 system - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology crispr cas9 cath l plasmid
Crispr Cas9 Cath L Plasmid, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/crispr cas9 cath l plasmid/product/Santa Cruz Biotechnology
Average 94 stars, based on 1 article reviews
crispr cas9 cath l plasmid - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
Cell Signaling Technology Inc crispr–cas effector crrnps
Model for regulation of the RNAse, DNase, and cOA synthetase activities of the Pfu Type III-B effector crRNP in providing anti-viral immunity. Inactive Type III-B <t>crRNPs</t> become activated upon interaction with expressed viral RNA. crRNA-guided base-pairing to the viral RNA and Cas protein recognition of the PFS results in conformational changes that trigger three important activities: viral RNA cleavage by Cmr4, viral DNA cleavage by the HD domain of Cmr2 (a member of the Cas10 superfamily), and ATP dependent production of cyclic oligoadenylates (cOA) by the Palm domain of Cmr2. The cOA second messengers allosterically regulate the trans-acting Csx1 enzyme by binding to the CARF domain to trigger HEPN RNase activity. Clearance of the viral DNAs and RNAs provides immunity and restores the crRNPs back to the inactive state. Under conditions of controlled immunity, Csx1 degrades and inactivates cOA signaling molecules using the HEPN domain, to provide an auto-inhibitory off-switch of Csx1 RNase activation. Inefficient degradation of cOA molecules by the Csx1 or failure to efficiently destroy the viral RNAs or viral genome may cause Csx1 to destroy both viral and cellular RNA molecules, leading to cellular dormancy or death.
Crispr–Cas Effector Crrnps, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/crispr–cas effector crrnps/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
crispr–cas effector crrnps - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Cell Signaling Technology Inc crispr–cas effector crrnp
Model for regulation of the RNAse, DNase, and cOA synthetase activities of the Pfu Type III-B effector crRNP in providing anti-viral immunity. Inactive Type III-B <t>crRNPs</t> become activated upon interaction with expressed viral RNA. crRNA-guided base-pairing to the viral RNA and Cas protein recognition of the PFS results in conformational changes that trigger three important activities: viral RNA cleavage by Cmr4, viral DNA cleavage by the HD domain of Cmr2 (a member of the Cas10 superfamily), and ATP dependent production of cyclic oligoadenylates (cOA) by the Palm domain of Cmr2. The cOA second messengers allosterically regulate the trans-acting Csx1 enzyme by binding to the CARF domain to trigger HEPN RNase activity. Clearance of the viral DNAs and RNAs provides immunity and restores the crRNPs back to the inactive state. Under conditions of controlled immunity, Csx1 degrades and inactivates cOA signaling molecules using the HEPN domain, to provide an auto-inhibitory off-switch of Csx1 RNase activation. Inefficient degradation of cOA molecules by the Csx1 or failure to efficiently destroy the viral RNAs or viral genome may cause Csx1 to destroy both viral and cellular RNA molecules, leading to cellular dormancy or death.
Crispr–Cas Effector Crrnp, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/crispr–cas effector crrnp/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
crispr–cas effector crrnp - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Model for regulation of the RNAse, DNase, and cOA synthetase activities of the Pfu Type III-B effector crRNP in providing anti-viral immunity. Inactive Type III-B crRNPs become activated upon interaction with expressed viral RNA. crRNA-guided base-pairing to the viral RNA and Cas protein recognition of the PFS results in conformational changes that trigger three important activities: viral RNA cleavage by Cmr4, viral DNA cleavage by the HD domain of Cmr2 (a member of the Cas10 superfamily), and ATP dependent production of cyclic oligoadenylates (cOA) by the Palm domain of Cmr2. The cOA second messengers allosterically regulate the trans-acting Csx1 enzyme by binding to the CARF domain to trigger HEPN RNase activity. Clearance of the viral DNAs and RNAs provides immunity and restores the crRNPs back to the inactive state. Under conditions of controlled immunity, Csx1 degrades and inactivates cOA signaling molecules using the HEPN domain, to provide an auto-inhibitory off-switch of Csx1 RNase activation. Inefficient degradation of cOA molecules by the Csx1 or failure to efficiently destroy the viral RNAs or viral genome may cause Csx1 to destroy both viral and cellular RNA molecules, leading to cellular dormancy or death.

Journal: Nucleic Acids Research

Article Title: Regulation of the RNA and DNA nuclease activities required for Pyrococcus furiosus Type III-B CRISPR–Cas immunity

doi: 10.1093/nar/gkaa176

Figure Lengend Snippet: Model for regulation of the RNAse, DNase, and cOA synthetase activities of the Pfu Type III-B effector crRNP in providing anti-viral immunity. Inactive Type III-B crRNPs become activated upon interaction with expressed viral RNA. crRNA-guided base-pairing to the viral RNA and Cas protein recognition of the PFS results in conformational changes that trigger three important activities: viral RNA cleavage by Cmr4, viral DNA cleavage by the HD domain of Cmr2 (a member of the Cas10 superfamily), and ATP dependent production of cyclic oligoadenylates (cOA) by the Palm domain of Cmr2. The cOA second messengers allosterically regulate the trans-acting Csx1 enzyme by binding to the CARF domain to trigger HEPN RNase activity. Clearance of the viral DNAs and RNAs provides immunity and restores the crRNPs back to the inactive state. Under conditions of controlled immunity, Csx1 degrades and inactivates cOA signaling molecules using the HEPN domain, to provide an auto-inhibitory off-switch of Csx1 RNase activation. Inefficient degradation of cOA molecules by the Csx1 or failure to efficiently destroy the viral RNAs or viral genome may cause Csx1 to destroy both viral and cellular RNA molecules, leading to cellular dormancy or death.

Article Snippet: Pyrococcus furiosus ( Pfu ) is a hyperthermophilic archaeon that contains three distinct functional CRISPR–Cas effector crRNPs: two DNA-targeting systems (Types I-A (Csa) and I-B (formerly known as I-G) (Cst) ( )) and a Type III-B (Cmr) system ( ) shown to destroy both DNA and RNA targets in a transcription-coupled manner ( , , , ).

Techniques: Binding Assay, Activity Assay, Activation Assay